Age Rating
Cancer Risk Capturas de tela
About Cancer Risk
The Rotterdam Prostate Cancer Risk Calculator is based on ERSPC, Rotterdam, data and supported by the Prostate Cancer Research Foundation, Rotterdam (SWOP)
The Prostate Cancer Research Foundation, Rotterdam, Stichting Wetenschappelijk Onderzoek Prostaatkanker (SWOP), is an initiative of the Department of Urology of the Erasmus MC, the University and Medical Centre of Rotterdam, in The Netherlands. Its goal is the financial support of scientific research projects in the field of prostate cancer, as well as other cancers of the urinary tract.
Please be aware that the Rotterdam Prostate Cancer Risk Calculator for iOS cannot be 100% accurate at predicting the presence or absence of prostate cancer. It is designed to help calculate your risk, not give a definitive diagnosis.
The Rotterdam Prostate Cancer Risk Calculator for iOS provides a general risk calculation based on your PSA level and other information.
While knowing your PSA level is helpful, the decision to have a PSA test has to be taken seriously after weighing up all factors and discussing the implications with your GP or hospital doctor.
It is possible that prostate cancer will not be found even if you have an elevated PSA. However, it may be present even if your PSA level is low.
Your doctor may want to take further tests. If you have doubts or questions about your health, you should always contact your GP or hospital doctor. This is particularly important if you have questions which arise from the use of our prostate cancer risk calculator.
It cannot be ruled out that the way the Rotterdam Prostate Cancer Risk Calculator for iOS is used, or the indications given by it, are interpreted in a manner that is not appropriate. The creators of the Rotterdam Prostate Cancer Risk Calculator for iOS do not accept any responsibility in any respect.
The European Randomized Study of Screening for Prostate Cancer has published its 11-year follow-up results (New England Journal of Medicine, March 15 2012). Once again, they demonstrate that screening does significantly reduce death from prostate cancer. The latest study confirms that a man who undergoes PSA testing will have his risk of dying from prostate cancer reduced by 29%.
ERSPC is the world’s largest randomized prostate cancer screening study. It was designed to investigate whether early detection and treatment of prostate cancer might reduce disease-specific mortality and also help to identify men at risk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to 69, across Europe to either a screening arm or a control group.
Designed and developed for iOS by Nuno Azevedo of Ydeal.net Software LDA
The Prostate Cancer Research Foundation, Rotterdam, Stichting Wetenschappelijk Onderzoek Prostaatkanker (SWOP), is an initiative of the Department of Urology of the Erasmus MC, the University and Medical Centre of Rotterdam, in The Netherlands. Its goal is the financial support of scientific research projects in the field of prostate cancer, as well as other cancers of the urinary tract.
Please be aware that the Rotterdam Prostate Cancer Risk Calculator for iOS cannot be 100% accurate at predicting the presence or absence of prostate cancer. It is designed to help calculate your risk, not give a definitive diagnosis.
The Rotterdam Prostate Cancer Risk Calculator for iOS provides a general risk calculation based on your PSA level and other information.
While knowing your PSA level is helpful, the decision to have a PSA test has to be taken seriously after weighing up all factors and discussing the implications with your GP or hospital doctor.
It is possible that prostate cancer will not be found even if you have an elevated PSA. However, it may be present even if your PSA level is low.
Your doctor may want to take further tests. If you have doubts or questions about your health, you should always contact your GP or hospital doctor. This is particularly important if you have questions which arise from the use of our prostate cancer risk calculator.
It cannot be ruled out that the way the Rotterdam Prostate Cancer Risk Calculator for iOS is used, or the indications given by it, are interpreted in a manner that is not appropriate. The creators of the Rotterdam Prostate Cancer Risk Calculator for iOS do not accept any responsibility in any respect.
The European Randomized Study of Screening for Prostate Cancer has published its 11-year follow-up results (New England Journal of Medicine, March 15 2012). Once again, they demonstrate that screening does significantly reduce death from prostate cancer. The latest study confirms that a man who undergoes PSA testing will have his risk of dying from prostate cancer reduced by 29%.
ERSPC is the world’s largest randomized prostate cancer screening study. It was designed to investigate whether early detection and treatment of prostate cancer might reduce disease-specific mortality and also help to identify men at risk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to 69, across Europe to either a screening arm or a control group.
Designed and developed for iOS by Nuno Azevedo of Ydeal.net Software LDA
Show More
Novidades da Última Versão 3.2.3
Last updated on Sep 22, 2020
Versões Antigas
Bug Fixed
Show More
Version History
3.2.3
Sep 22, 2020
Bug Fixed
3.2.2
Jul 22, 2020
Update About
3.2.1
May 5, 2020
Bug Fixed
3.2.0
Apr 1, 2020
Melhoramento do cálculo
3.1.2
Apr 10, 2019
Novo Sobre
3.1.1
Oct 13, 2018
Nova informação adicionada
3.1.0
Sep 4, 2018
RMN é a abreviatura de Ressonância Magnética Nuclear. Uma ressonância magnética da próstata é classificada de acordo com o sistema PIRADS, onde PIRADS 1 é uma doença benigna e PIRADS 5 é uma patologia mais agressiva. Para esta calculadora de risco foi usada a versão 1 do PIRADS.
2.6.6
Mar 1, 2018
Bug fixed
2.6.5
Jan 12, 2018
Bug fixed
2.6.4
Jan 11, 2018
Bug fix
2.6.3
Jan 5, 2018
support for iPhone X and bug fix
2.6.2
Nov 4, 2017
support for iPhone X
2.6.1
Nov 29, 2016
Bug fixed - Estonian language
2.6
Sep 26, 2016
Includes support for Estonian language
2.5
Oct 29, 2015
In-App language selection;
Send your results by email to your doctor.
Send your results by email to your doctor.
2.1
Oct 20, 2014
Minor issues fixed.
Add Chinese, Spanish and Portuguese languages.
Add Chinese, Spanish and Portuguese languages.
2.0
Apr 3, 2014
Add iPad support and improve performance.
1.2
Dec 5, 2013
This version is now compatible with previous iOS versions (pre-iOS7).
1.1
Nov 10, 2013
Updated algorithm!
1.0
Oct 25, 2013
Preço de Cancer Risk
Hoje:
R$ 9,90
O Mais Baixo:
R$ 9,90
O Mais Alto:
R$ 10,90
Cancer Risk FAQ
Clique aqui para saber como baixar Cancer Risk em um país ou região restrita.
Confira a lista a seguir para ver os requisitos mínimos de Cancer Risk.
iPhone
Requer o iOS 9.3 ou posterior.
iPad
Requer o iPadOS 9.3 ou posterior.
iPod touch
Requer o iOS 9.3 ou posterior.
Cancer Risk suporta Português, Alemão, Chinês simplificado, Espanhol, Estoniano, Holandês, Inglês